Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-006968
Filing Date
2023-03-03
Accepted
2023-03-03 16:13:06
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9647
  Complete submission text file 0000899243-23-006968.txt   11330
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Issuer) CIK: 0001435049 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 415-801-8100
Jerel Davis (Reporting) CIK: 0001745958 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37345 | Film No.: 23704085